Reversal of osteoporotic changes of mineral composition in femurs of diabetic rats by insulin.
Insulin plays an important role in bone prevention of diabetic osteoporosis, but little is known about the relation between the bone mineral density (BMD) increase and the change of mineral element content after treated with insulin. To address this problem, male Wistar rats were randomly divided into three groups: normal group (n = 6), streptozotocin-induced diabetic group (n = 5), and streptozotocin-induced diabetic group with insulin treatment (n = 5). The femoral BMD was measured by dual energy X-ray absorptiometry, and the element content was determined by inductively coupled plasma atomic emission spectrometry (ICP-AES). The results showed that the femoral BMD in diabetic group was significantly lower than that in normal group (P < 0.01) but restored by insulin treatment (P < 0.01 vs diabetic group). ICP-AES analysis revealed that the element content of calcium (Ca), phosphorous (P), magnesium (Mg), strontium (Sr), and potassium (K) in diabetic group were remarkably lower than those in normal group (P < 0.01) but only Ca, P, and Mg content were significantly increased compared with diabetic group (P < 0.05) after insulin treatment. However, no significant differences were observed in element zinc (Zn) content among three groups. Our findings suggested that the loss of Ca, P, Mg, Sr, and K content accounted for the lower BMD in streptozotocin-induced diabetes rats, insulin treatment could restore BMD by increasing the content of Ca, P, and Mg.
Zhang
Xiaolin
X
School of Life Sciences, Graduate University of Chinese Academy of Sciences, 19A Yuquan Road, Beijing, People's Republic of China.
Fei
Yurong
Y
Zhang
Min
M
Wei
Dan
D
Li
Ming
M
Ding
Wenjun
W
Yang
Jianhong
J
D015502:Absorptiometry, Photon; D000818:Animals; D015519:Bone Density / Q000187:drug effects*; D002118:Calcium / Q000378:metabolism; D003921:Diabetes Mellitus, Experimental / Q000378:metabolism*; D005269:Femur / Q000187:drug effects* / Q000378:metabolism; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000494:pharmacology; D007328:Insulin / Q000008:administration & dosage / Q000494:pharmacology*; D008274:Magnesium / Q000378:metabolism; D008297:Male; D010758:Phosphorus / Q000378:metabolism; D011188:Potassium / Q000378:metabolism; D011897:Random Allocation; D051381:Rats; D017208:Rats, Wistar; D013054:Spectrophotometry, Atomic; D013324:Strontium / Q000378:metabolism
D007004:Hypoglycemic Agents; D007328:Insulin; D010758:Phosphorus; D008274:Magnesium; D011188:Potassium; D002118:Calcium; D013324:Strontium